VRX Financial Facts

Research and development costs, net: 11.95M
Shares used in per share computation - Diluted: 82.64M
See Full Income Statement

Total Valeant stockholders' equity: 352.99M
Accounts receivable, net: 183.79M
See Full Balance Sheet

(VRX) Earnings

  |   Expand Research on VRX
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate N/A Revenue Growth Rate N/A
Average % Move 1-Wk after EPS N/A Normal Earnings Time N/A
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details